Is class III β-tubulin a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer?
TUBB3 was a strong predictive marker in recurrent and metastatic gastric cancer patients receiving taxane-based first-line palliative chemotherapy. No clinical impact of ERCC1 was evident in this setting.
Anterior fusion is effective for the treatment of low-back pain due to degenerative disc disease, when associated to vertebral plate changes; as the pathology is mainly anterior. We prefer an anterior mini-invasive approach; furthermore, posterior elements are intact and canal exploration is unnecessary. However, an additional posterior osteosynthesis is preferable in Modic type II, as non union rate is increased by fatty degenerative involution.